Common approaches for profiling patients and phenotyping disorders may include the following tools: checklists, questionnaires, interviews, physical examinations, imaging, laboratory tests, and psychological/psychiatric evaluations.
The goals of this study were to use proteomic mass spectrometry approaches for profiling, fractionation, and identification of serum proteins from breast cancer patients for discovery of new biomarkers of stage and nodal status.
However, similar approaches for profiling PKMT activity on a proteome-wide scale have not been described.
Three complementary approaches for profiling glycans are now assuming prominent positions: lectin/antibody arrays, mass spectrometry, and metabolic labeling.
Beside the classical approaches for profiling transcripts like Northern blots, reverse-transcriptase (q PCR, RACE (rapid amplification of cDNA ends), and microarrays, the recent development of RNAseq has revolutionized transcriptomics.
Semeraro et al. [74] uses a different approach for profile construction.
Our specific correlation approach for profile analysis may therefore be adapted to peak shift determination in usual spectral or angular RWGs based detection techniques [ 2– 4, 7].
However, verifying this would require much deeper EST sampling and a methodologically consistent approach for profiling transcripts (e.g. microarrays).
In the present study we used label-free quantitative proteomics approach for profiling the proteome of resected cancer and autologous normal kidney tissues.
In this work, we described a new interesting approach for profiling circulating miRNAs in plasma samples using a chip-based platform, the QuantStudio 3D digital PCR.
